Observational studyJournal of assisted reproduction and genetics2025
Impact of controlled ovarian hyperstimulation protocols on aneuploidy of preimplantation blastocysts in women aged 21-37 years old.
Observational study in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeThis study aimed to explore whether different controlled ovarian hyperstimulation (COH) protocols were associated with the incidence of aneuploid blastocysts in cycles undergoing preimplantation genetic testing for aneuploidy (PGT-A).
methodsA retrospective analysis was conducted on 5525 blastocysts from 1722 women (21-37 years old) who underwent PGT-A cycles utilizing next-generation sequencing (NGS). The cohorts included 240 cycles employing the gonadotropin-releasing hormone agonist (GnRH-a) short protocol, 698 cycles using the GnRH-a long protocol, and 784 cycles utilizing the GnRH antagonist (GnRH-ant) protocol.
resultsA significantly elevated rate of blastocyst aneuploidy was observed in the GnRH-a short protocol group relative to both the long protocol and antagonist protocol groups (44.05% vs. 36.00% vs. 37.90%). Multivariable regression analyses, with the GnRH-a long protocol serving as the reference category, indicated that the short protocol was independently correlated with higher aneuploidy rates (OR = 1.30, 95% CI 1.06-1.60, P = 0.012). This association was particularly evident among younger patients (< 35 years) possessing preserved ovarian reserve (AMH ≥ 1.2 ng/mL) (OR = 1.38, 95% CI 1.02-1.87, P = 0.036). Although non-significant, the short protocol also trended towards a higher aneuploidy rate compared to the antagonist protocol (OR = 1.12, 95% CI 0.89-1.41, P = 0.32).
conclusionsThe findings suggest that, in the population studied (21-37 years), the GnRH-a short protocol is associated with a higher incidence of blastocyst aneuploidy compared to the long protocol, particularly in younger individuals (< 35 years) with normal ovarian reserve (AMH ≥ 1.2 ng/mL). These results highlight the need for tailored COH protocol selection based on patient characteristics in PGT-A cycles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.